DXCM logo DexCom +
DexCom
+

DexCom (DXCM) Business News

Track DexCom in real time with a live news feed covering DexCom stock news, official press releases, company announcements, and an archive of historical DexCom news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
4:45 PM | Monday | Jul 13, 2026 Business Wire

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

News Thumbnail
9:00 AM | Thursday | Jul 9, 2026 GuruFocus

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

News Thumbnail
8:30 AM | Thursday | Jul 9, 2026 Business Wire

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

News Thumbnail
9:00 AM | Thursday | Jul 9, 2026 GuruFocus

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

News Thumbnail
8:30 AM | Thursday | Jul 9, 2026 Business Wire

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

News Thumbnail
10:45 AM | Wednesday | Jul 8, 2026 Zacks Investment Research

Here's Why DexCom (DXCM) is a Strong Growth Stock

News Thumbnail
3:36 PM | Monday | Jul 6, 2026 Zacks Investment Research

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

News Thumbnail
12:27 PM | Friday | Jul 3, 2026 PRNewsWire

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

News Thumbnail
2:10 AM | Thursday | Jul 2, 2026 Seeking Alpha

DexCom: The Growth Thesis Still Needs To Be Proven

News Thumbnail
9:36 AM | Friday | Jun 26, 2026 Zacks Investment Research

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

News Thumbnail
10:31 AM | Wednesday | Jun 24, 2026 Zacks Investment Research

DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans

News Thumbnail
9:00 AM | Tuesday | Jun 23, 2026 Business Wire

Dexcom Further Advances Vision of Glucose Biosensing for All

News Thumbnail
8:45 AM | Saturday | Jun 20, 2026 MarketBeat

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

News Thumbnail

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Business Wire

4:45 PM | Monday | Jul 13, 2026

news photo
Loading...

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real‑time glucose readings for an industry‑leading 15.5 days5. Building on the performance of Dexcom CGM whi.

Read full article redirect
4:45 PM | Monday | Jul 13, 2026

Dexcom G7 15 Day Receives Health Canada Authorization: Extending Wear and Continuity for Canadian Adults Living with Diabetes

Business Wire

BURNABY, British Columbia--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, announced today that Health Canada has authorized the Dexcom G7 15 Day Continuous Glucose Monitoring System (CGM) for people 18 years and older living with diabetes. Dexcom G7 15 Day is the longest‑lasting and most accurate1-4 CGM system authorized by Health Canada, providing real‑time glucose readings for an industry‑leading 15.5 days5. Building on the performance of Dexcom CGM whi.

Read full article arrow
News Thumbnail
9:00 AM | Thursday | Jul 9, 2026

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

GuruFocus

[url="]DexCom, Inc.[/url] (NASDAQ: DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July

Read full article arrow
News Thumbnail
8:30 AM | Thursday | Jul 9, 2026

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day.
The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will.

Read full article arrow
News Thumbnail
9:00 AM | Thursday | Jul 9, 2026

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

GuruFocus

[url="]DexCom, Inc.[/url] (NASDAQ: DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July

Read full article arrow
News Thumbnail
8:30 AM | Thursday | Jul 9, 2026

Dexcom Schedules Second Quarter 2026 Earnings Release and Conference Call for July 30, 2026 at 4:30 p.m. Eastern Time

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its second quarter 2026 financial results after market close on Thursday, July 30, 2026. Management will hold a conference call to review the company's second quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day.
The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will.

Read full article arrow
News Thumbnail
10:45 AM | Wednesday | Jul 8, 2026

Here's Why DexCom (DXCM) is a Strong Growth Stock

Zacks Investment Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Read full article arrow
News Thumbnail
3:36 PM | Monday | Jul 6, 2026

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

Zacks Investment Research

DexCom, Inc.  DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong first-quarter 2026 performance and a robust international foothold are expected to contribute further.

Read full article arrow
News Thumbnail
12:27 PM | Friday | Jul 3, 2026

Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Read full article arrow
News Thumbnail
2:10 AM | Thursday | Jul 2, 2026

DexCom: The Growth Thesis Still Needs To Be Proven

Seeking Alpha

DexCom faces a pivotal transition as GLP-1 adoption threatens its core insulin-treated diabetes market. DXCM aims to expand CGM adoption to Type 2 non-insulin patients, but commercial uptake remains unproven despite positive clinical trial results. At 28x earnings, DXCM's valuation is not demanding, yet offers limited upside given execution risks and the need for evidence of new market penetration.

Read full article arrow
News Thumbnail
9:36 AM | Friday | Jun 26, 2026

Abbott vs. DexCom: Which CGM Stock Is the Better Option Right Now?

Zacks Investment Research

DXCM outpaces Abbott with expanding CGM access, new product launches and broader coverage, making it the stronger stock to watch now.

Read full article arrow
News Thumbnail
10:31 AM | Wednesday | Jun 24, 2026

DexCom to Roll Out Reimagined Stelo App With Global Expansion Plans

Zacks Investment Research

DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening its glucose insights push.

Read full article arrow
News Thumbnail
9:00 AM | Tuesday | Jun 23, 2026

Dexcom Further Advances Vision of Glucose Biosensing for All

Business Wire

SAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing, today announced at Aspen Ideas: Health a series of milestones that advance its vision of making glucose biosensing more accessible. Notably, the company announced pediatric clearance for the Stelo Glucose Biosensor and the launch of its fully reimagined Stelo app experience in July for Apple iPhone and Android users in the United States.“Glucose matters for everyone and better understanding it can h.

Read full article arrow
News Thumbnail
8:45 AM | Saturday | Jun 20, 2026

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend

MarketBeat

The GLP-1 revolution is quietly continuing even as investor interest has moved on to more timely topics. One of the best ways to access the fast-growing weight loss drug space is via makers like Novo Nordisk NYSE: NVO or Eli Lilly NYSE: LLY, the leading companies responsible for developing and manufacturing products like Ozempic and Zepbound.

Read full article arrow
News Thumbnail